On Thursday, Shares of Paypal Holdings Inc (NASDAQ:PYPL), included 2.07 % and shut at $39.88 inside the end purchasing and offering session. The last exchanging scope of the stock ranges amongst $38.95 and $40.06. Recently PayPal and Ipsos released their third annual cross-border commerce report. The global insights research, which investigated the online domestic and cross-border shopping habits of more than 28,000 consumers in 32 countries, reveals new opportunities for merchants to expand their international sales.
Shopping internationally on mobile devices gains traction
In Asia Pacific1, consumers claim that on average, 37 percent of cross-border purchases are made on a mobile device, the majority of which are on a smartphone. In fact, 68 percent of all cross-border shoppers in the Asia Pacific region stated making a cross-border purchase on a smartphone in the past 12 months. In China, the survey saw a marked increase in the shift to mobile purchasing between 2015 and 2016, with an average of 35 percent of cross-border purchases being made on a smartphone in 2016 vs. 27 percent in 2015.
Shares of Hologic, Inc. (NASDAQ:HOLX), added 2.93 % and shut at $38.58 inside the last exchanging session. The rest of the purchasing and offering scope of the stock levels among $37.24 and $38.67. The association’s commercial center capitalization is $11.01 Billion with the general uncommon loads of 277.07 million. Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment provides Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, instrumentation, Invader chemistry platform, ThinPrep system, fetal fibronectin tests, Procleix family of assays for blood screening, and virology and infectious disease products. The Breast Health segment offers breast imaging and related products and accessories, counting digital and film-based mammography systems; computer-aided detection (CAD) for mammography; invasive breast biopsy devices; breast biopsy site markers; breast biopsy guidance systems; and breast brachytherapy products. This segment also provides Dimensions platform, a mammography gantry for 2D and tomosynthesis image acquisition and display; C-View that provides a 2D image; Selenia digital mammography platform; and SecurView Workstations. The GYN Surgical segment offers NovaSure system to treat women suffering from abnormal uterine bleeding; and MyoSure system for the hysteroscopic removal of fibroids. The Skeletal Health segment provides discovery and horizon X-ray bone densitometers that assess the bone density of fracture sites; and mini C-arm imaging systems to perform minimally invasive surgical procedures on a patients extremities, such as the hand, wrist, knee, foot, and ankle. Hologic, Inc. sells its products through direct sales and service forces, and a network of independent distributors and sales representatives.